Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center;Impacto de la revisión del tratamiento ambulatorio con agentes antimicrobiales administrados parenteralmente (OPAT) previo al alta por un equipo multidisciplinario en un centro médico académico

Annals of Pharmacotherapy

Volumn 45, Issue 11, 2011, Pages 1329-1337

  Heintz, Brett H ^a,b   Halilovic, Jenana ^b,c   Christensen, Cinda L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Antimicrobial stewardship; OPAT; Outpatient parenteral antimicrobial therapy

Indexed keywords

ANTIMICROBIAL THERAPY; CENTRAL VENOUS CATHETERIZATION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL DISCHARGE; HUMAN; OBSERVATIONAL STUDY; OUTPATIENT CARE; PATIENT CARE; PATIENT REFERRAL; PATIENT SATISFACTION; PHARMACIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; REVIEW; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ANTI-BACTERIAL AGENTS; CASE MANAGEMENT; COST-BENEFIT ANALYSIS; DRUG TOXICITY; HUMANS; INFECTION CONTROL; INFUSIONS, PARENTERAL; OUTPATIENTS; PATIENT CARE; PATIENT DISCHARGE; PHARMACISTS; PHYSICIANS;

EID: 80155194899     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q240     Document Type: Review

References (41)

1. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974;54:358-60.
2. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004;38:1651-72. doi 10.1086/420939
3. Tice AD. Handbook of outpatient parenteral antimicrobial therapy. 1st ed. New York, NY: Scientic American Medicine, Inc., 2005.
4. Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 2010;51(suppl 2):S198-208. DOI 10.1086/653520
5. Yong C, Fisher DA, Sklar GE, Li SC. A cost analysis of outpatient parenteral antibiotic therapy (OPAT): an Asian perspective. Int J Antimicrob Agents 2009;33:46-51. DOI 10.1016/j.ijantimicag.2008.07.016
6. Wai AO, Frighetto L, Marra CA, Chan E, Jewesson PJ. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics 2000;18:451-7.
7. Nguyen HH. Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis 2010;51(suppl 2):S220-3. doi 10.1086/653523
8. Kieran J, O'Reilly A, Parker J, Clarke S, Bergin C. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis 2009; 28:1369-74. DOI 10.1007/s10096-009-0794-5
9. Goodfellow AF, Wai AO, Frighetto L, et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002;36:1851-5.
10. Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009;64: 1316-24. DOI 10.1093/jac/dkp343
11. Wiselka MJ, Nicholson KG. Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital. J Infect 1997;35:73-6.
12. Nathwani D, Morrison J. Parenteral therapy in the outpatient or home setting: evidence, evaluation and future prospects. J Infect 2001;42:173-5. DOI 10.1053/jinf.2001.0823
13. Matthews PC, Conlon CP, Berendt AR, et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007;60:356-62.
14. Farry JK, Miles CD, Collins CD, Malani PN. Adverse events among renal transplant recipients receiving outpatient parenteral antimicrobial in-fusion therapy. Transpl Infect Dis 2009;11:284-5. DOI 10.1111/j.1399-3062.2009.00377.x
15. Upton A, Ellis-Pegler RB, Woodhouse A. Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. N Z Med J 2004;117:U1020.
16. Methodology for estimating inpatient care costs. Chicago, IL: University HealthSystem Consortium, 2007.
17. Tice AD, Rehm SJ. Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy. Clin Infect Dis 2010;51(suppl 2):S171-5. Epub 7 Jul 2009. DOI 10.1093/jac/dkp245
18. Nathwani D. Developments in outpatient parenteral antimicrobial therapy (OPAT) for gram-positive infections in Europe, and the potential impact of daptomycin. J Antimicrob Chemother 2009;64:447-53. DOI 10.1093/jac/dkp245
19. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006;5:2.
20. Rehm SJ, Tice A. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis 2010;51(suppl 2):S176-82.
21. White HA, Davis JS, Kittler P, Currie BJ. Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting. Intern Med J 2011;41:668-73. DOI 10.1111/j.14455994.2009.02136.x
22. White H, Bell E, Lamont E, Semple L, Seaton RA. One-year outcome following outpatient parenteral antibiotic therapy (OPAT) treated bone and joint infections. J Infect 2007;55:e79-80. DOI 10.1016/j.jinf.2007.04.115
23. Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med 2003;114:723-8. DOI 10.1016/S0002-9343(03)00231-6
24. Tice AD. Outpatient parenteral antimicrobial therapy for osteomyelitis. Infect Dis Clin North Am 1998;12:903-19. DOI 10.1016/S0891-5520(05)70027-1
25. Tice A. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries. Chemotherapy 2001;47(suppl 1):5-16. DOI 10.1159/000048563
26. Williams DN, Raymond JL. Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues. Clin Pharmacokinet 1998;35:65-77.
27. Slavik RS, Jewesson PJ. Selecting antibacterials for outpatient parenteral antimicrobial therapy: pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 2003;42:793-817.
28. Craig WA. Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapy. Int J Antimicrob Agents 1995;5:19-22.
29. Ingram PR, Lye DC, Fisher DA, Goh WP, Tam VH. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy. Int J Antimicrob Agents 2009;34:570-4. DOI 10.1016/j.ijantimicag.2009.07.011
30. Ng PK, Ault MJ, Ellrodt AG, Maldonado L. Peripherally inserted central catheters in general medicine. Mayo Clin Proc 1997;72:225-33doi 10.4065/72.3.225
31. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601. DOI 10.1001/jama.271.20.1598
32. O'Grady N P, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002;30:476-89. DOI 10.1086/344188
33. Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999;106: 44-9. DOI 10.1016/S0002-9343(98)00362-3
34. Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Communitybased outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother 2009;63:1034-42. DOI 10.1093/jac/dkp131
35. Rehm SJ, Weinstein AJ. Home intravenous antibiotic therapy: a team approach. Ann Intern Med 1983;99:388-92.
36. Chary A, Tice AD, Martinelli LP, Liedtke LA, Plantenga MS, Strausbaugh LJ. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis 2006;43:1290-5doi 10.1086/508456
37. Tice AD. The importance of teamwork for outpatient parenteral antibiotic therapy. Int J Antimicrob Agents 1995;5:13-7doi 10.1016/0924-8579(94)00052-V
38. Tice AD. Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: medical, socioeconomic, and legal issues. The team concept. Hosp Pract (Off Ed) 1993;28(suppl 1):6-10.
39. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy 2002;22:63S-70S. DOI 10.1592/phco.22.4.63S.33653
40. Kane RE, Jennison K, Wood C, Black PG, Herbst JJ. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol 1988;4:84-9.
41. Nolet BR. Update and overview of outpatient antimicrobial therapy reimbursement. Clin Infect Dis 2010;15(suppl 2):s216-9.